Tag Archives: Labiotech.eu

Europe, sans Basel, Copenhagen and Paris, taking on the US biotech titans.

The News: Since its birthday back in 1776, America has seen itself as the land of the new–and Europe as a landmass caught in the past. Nowhere is that truer… Read more »

Gut-check alert: Don’t take your microbiome for granted. Seriously! And some gut-wrenching stock picks.

The News: Last month it was quietly reported that scientists working on the gut microbiome have discovered and isolated more than 100 completely new species of bacteria from healthy people’s… Read more »

And now for something completely different in biotech: Lab-grown, “clean” meat. If Bill Gates and Warren Buffett like the idea…well?

The Premise: Contemplate a world where eating meat derived from animals is a thing of the past. Ridiculous, you say. But during the past year, the field of cultured (or… Read more »

UK’s Momentum Bio could help millions of hospital patients with first diagnostic test for blood infections that says whether or not to use antibiotics.

The News: Momentum Biosciences Ltd. (Cardiff UK) aims to pare back the unnecessary use of antimicrobial drugs in hospitals. To do this, it is developing molecular diagnostics that, within hours,… Read more »

Maat Pharma’s microbiome therapy shows early promise in cancer patients treatment. Are common gut bugs leading the charge to investment riches?

The News: A clinical trial run by MaaT Pharma SA (Lyon FRA) has shown that restoring the microbiome of patients undergoing chemotherapy has potential to improve the outcome of patients… Read more »

This Dutch biotech startup is quietly developing a novel immune-cell approach for cancer. Can it muscle in on established rivals?

The News: Lava Therapeutics BV (Hertogenbosch NLD) is quietly developing a cancer immunotherapy that arms a rare type of immune cell called gamma delta T cells, Labiotech.eu reports. The company’s… Read more »

Tissue engineering and regenerative medicine starting to elbow its way into media coverage; watch out you cancer “miracle cures.”

The News: A group of researchers in Spain has developed a silk biomaterial that can increase the survival of transplanted stem cells into the brain, improving recovery after a stroke… Read more »

Europe frets over waning IPO biotech scene while US pricings and new registrations keep chugging along.

The News: Over the last two weeks, several biotech companies in Europe have decided to postpone IPOs on the stock markets there prompting speculation that biotech stocks are underperforming, according… Read more »